Q1 2018 |
62 |
$152M |
+$67.2M |
-$17.8M |
+$49.3M |
ESPR, IMMU, GBT, HUM, BIIB
|
13F-HR |
5/15/2018, 04:13 PM |
Q4 2017 |
61 |
$154M |
+$30.6M |
-$23.9M |
+$6.65M |
ESPR, CELG, IMMU, BIIB, HUM
|
13F-HR |
2/14/2018, 03:32 PM |
Q3 2017 |
68 |
$184M |
|
|
|
CELG, ESPR, IMMU, CLVSQ, BIIB
|
New Holdings |
11/16/2017, 10:10 AM |
Q3 2017 |
68 |
$184M |
+$65.6M |
-$20.3M |
+$45.3M |
CELG, ESPR, IMMU, CLVSQ, BIIB
|
13F-HR |
11/14/2017, 03:31 PM |
Q2 2017 |
61 |
$177M |
+$58M |
-$19.4M |
+$38.5M |
CELG, ALXN, CLVSQ, SHPG, AGN
|
13F-HR |
8/14/2017, 05:01 PM |
Q1 2017 |
69 |
$202M |
+$73.5M |
-$34.5M |
+$39M |
MDCO, CELG, SHPG, AMGN, MRK
|
13F-HR |
5/15/2017, 05:20 PM |
Q4 2016 |
60 |
$167M |
+$39.4M |
-$45.7M |
-$6.33M |
RARE, BIIB, MDCO, CELG, AMGN
|
13F-HR |
2/14/2017, 03:06 PM |
Q3 2016 |
74 |
$281M |
|
|
|
RARE, BIIB, SHPG, CLVSQ, ZBH
|
New Holdings |
11/17/2016, 02:36 PM |
Q3 2016 |
79 |
$302M |
+$122M |
-$39.1M |
+$82.7M |
RARE, BIIB, SHPG, CLVSQ, ZBH
|
13F-HR |
11/14/2016, 04:03 PM |
Q2 2016 |
82 |
$246M |
+$110M |
-$45.3M |
+$65.1M |
CELG, ZBH, GILD, SHPG, ELV
|
Restatement |
11/4/2016, 04:05 PM |
Q1 2016 |
75 |
$273M |
+$155M |
-$28M |
+$127M |
CELG, CIXXXX, MDVN, BAX, ZBH
|
Restatement |
5/24/2016, 01:24 PM |
Q4 2015 |
64 |
$304M |
+$164M |
-$21.2M |
+$143M |
CELG, CIXXXX, AMGN, RARE, BAX
|
13F-HR |
2/16/2016, 03:23 PM |
Q3 2015 |
70 |
$253M |
+$97.4M |
-$30.6M |
+$66.7M |
ELV, VRX, RARE, GILD, CELG
|
13F-HR |
11/16/2015, 03:14 PM |
Q2 2015 |
69 |
$317M |
+$173M |
-$29.1M |
+$144M |
RARE, CELG, ESPR, GILD, AMGN
|
13F-HR |
8/14/2015, 04:28 PM |
Q1 2015 |
61 |
$235M |
+$124M |
-$11.5M |
+$113M |
PFE, ESPR, CELG, RARE, GILD
|
Restatement |
6/10/2015, 01:48 PM |
Q4 2014 |
59 |
$207M |
+$72.2M |
-$25.5M |
+$46.7M |
BIIB, CELG, GILD, MDTXXXX, XLV
|
13F-HR |
2/17/2015, 06:10 PM |
Q3 2014 |
61 |
$184M |
+$66.8M |
-$28.2M |
+$38.6M |
BIIB, GILD, AMGN, MDTXXXX, ABBV
|
13F-HR |
11/14/2014, 03:39 PM |
Q2 2014 |
64 |
$214M |
+$95.1M |
-$29.8M |
+$65.3M |
BIIB, AMGN, MDTXXXX, CELG, MRK
|
13F-HR |
8/14/2014, 04:17 PM |
Q1 2014 |
74 |
$216M |
+$115M |
-$16.1M |
+$98.5M |
BIIB, AMGN, MRK, CIXXXX, ZBH
|
13F-HR |
5/16/2014, 12:55 PM |
Q4 2013 |
69 |
$174M |
|
|
|
AMGN, MRK, BIIB, ZBH, GILD
|
13F-HR |
2/14/2014, 03:43 PM |